Chaotic neovascularization induced by aggressive fibrosarcoma cells overexpressing S-adenosylmethionine decarboxylase

International Journal of Biochemistry and Cell Biology

Volumn 43, Issue 3, 2011, Pages 441-454

  Paasinen Sohns, Aino ^a   Kääriäinen, Essi ^a   Yin, Miao ^a   Järvinen, Kristiina ^a   Nummela, Pirjo ^a   Hölttä, Erkki ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Angiogenesis; Fibrosarcoma; Invasion; S adenosylmethionine decarboxylase; Thrombospondin 1

Indexed keywords

ADENOSYLMETHIONINE DECARBOXYLASE; CD31 ANTIGEN; GELATINASE A; LAMININ; SCATTER FACTOR; SCATTER FACTOR RECEPTOR; TENASCIN; THROMBOSPONDIN 1; VASCULOTROPIN A;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASEMENT MEMBRANE; CANCER INVASION; CONTROLLED STUDY; ENDOTHELIUM CELL; FIBROBLAST; FIBROSARCOMA; GENE EXPRESSION; HUMAN; HUMAN CELL; MALIGNANT TRANSFORMATION; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; ONCOGENE RAS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; TUMOR GROWTH; TUMOR VASCULARIZATION;

ADENOSYLMETHIONINE DECARBOXYLASE; ANGIOGENESIS INDUCING AGENTS; ANIMALS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; COLLAGEN; DOWN-REGULATION; ENDOTHELIAL CELLS; FIBROSARCOMA; GELS; HEPATOCYTE GROWTH FACTOR; HUMANS; MATRIX METALLOPROTEINASE 2; MICE; NEOPLASM INVASIVENESS; NEOVASCULARIZATION, PATHOLOGIC; NIH 3T3 CELLS; PROTEIN ISOFORMS; THROMBOSPONDIN 1; TROPONIN C; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

MUS MUSCULUS; RODENTIA;

EID: 79751525323     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biocel.2010.11.018     Document Type: Article

References (80)

1. M. Auvinen, A. Paasinen, L.C. Andersson, and E. Holtta Ornithine decarboxylase activity is critical for cell transformation Nature 360 1992 355 358 (Pubitemid 23000675)
2. M. Auvinen, A. Paasinen-Sohns, H. Hirai, L.C. Andersson, and E. Holtta Ornithine decarboxylase- and ras-induced cell transformations: reversal by protein tyrosine kinase inhibitors and role of pp130CAS Mol Cell Biol 15 1995 6513 6525
3. M. Auvinen, A. Laine, A. Paasinen-Sohns, A. Kangas, L. Kangas, and O. Saksela Human ornithine decarboxylase-overproducing NIH3T3 cells induce rapidly growing, highly vascularized tumors in nude mice Cancer Res 57 1997 3016 3025 (Pubitemid 27315055)
4. G. Bergers, R. Brekken, G. McMahon, T.H. Vu, T. Itoh, and K. Tamaki Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis Nat Cell Biol 2 2000 737 744
5. G. Bergers, and L.E. Benjamin Tumorigenesis and the angiogenic switch Nat Rev Cancer 3 2003 401 410 (Pubitemid 37328844)
6. N. Bouck, V. Stellmach, and S.C. Hsu How tumors become angiogenic Adv Cancer Res 69 1996 135 174 (Pubitemid 26274885)
7. P.D. Brown, A.T. Levy, I.M. Margulies, L.A. Liotta, and W.G. Stetler-Stevenson Independent expression and cellular processing of Mr 72,000 type IV collagenase and interstitial collagenase in human tumorigenic cell lines Cancer Res 50 1990 6184 6191 (Pubitemid 20323672)
8. J.S. Carew, S.T. Nawrocki, V.K. Reddy, D. Bush, J.E. Rehg, and A. Goodwin The novel polyamine analogue CGC-11093 enhances the antimyeloma activity of bortezomib Cancer Res 68 2008 4783 4790
9. P. Carmeliet, and R.K. Jain Angiogenesis in cancer and other diseases Nature 407 2000 249 257
10. P. Carmeliet VEGF as a key mediator of angiogenesis in cancer Oncology 69 Suppl.3 2005 4 10 (Pubitemid 41680947)
11. R.A. Casero Jr., and L.J. Marton Targeting polyamine metabolism and function in cancer and other hyperproliferative diseases Nat Rev Drug Discov 6 2007 373 390 (Pubitemid 46705201)
12. V.P. Castle, X. Ou, K. O'Rourke, and V.M. Dixit High level thrombospondin 1 expression in two NIH 3T3 cloned lines confers serum- and anchorage-independent growth J Biol Chem 268 1993 2899 2903 (Pubitemid 23057926)
13. Y.S. Chang, E. di Tomaso, D.M. McDonald, R. Jones, R.K. Jain, and L.L. Munn Mosaic blood vessels in tumors: frequency of cancer cells in contact with flowing blood Proc Natl Acad Sci USA 97 2000 14608 14613 (Pubitemid 32016623)
14. S. Christian, R. Winkler, I. Helfrich, A.M. Boos, E. Besemfelder, and D. Schadendorf Endosialin (Tem1) is a marker of tumor-associated myofibroblasts and tumor vessel-associated mural cells Am J Pathol 172 2008 486 494 (Pubitemid 351282034)
15. K.M. Dameron, O.V. Volpert, M.A. Tainsky, and N. Bouck The p53 tumor suppressor gene inhibits angiogenesis by stimulating the production of thrombospondin Cold Spring Harb Symp Quant Biol 59 1994 483 489
16. F. de Fraipont, A.C. Nicholson, J.J. Feige, and E.G. Van Meir Thrombospondins and tumor angiogenesis Trends Mol Med 7 2001 401 407 (Pubitemid 32823989)
17. E. di Tomaso, D. Capen, A. Haskell, J. Hart, J.J. Logie, and R.K. Jain Mosaic tumor vessels: cellular basis and ultrastructure of focal regions lacking endothelial cell markers Cancer Res 65 2005 5740 5749 (Pubitemid 40911177)
18. M. Egeblad, and Z. Werb New functions for the matrix metalloproteinases in cancer progression Nat Rev Cancer 2 2002 161 174 (Pubitemid 37328786)
19. J. Fang, Y. Shing, D. Wiederschain, L. Yan, C. Butterfield, and G. Jackson Matrix metalloproteinase-2 is required for the switch to the angiogenic phenotype in a tumor model Proc Natl Acad Sci USA 97 2000 3884 3889 (Pubitemid 30226056)
20. N. Ferrara VEGF: an update on biological and therapeutic aspects Curr Opin Biotechnol 11 2000 617 624
21. N. Ferrara, and R.S. Kerbel Angiogenesis as a therapeutic target Nature 438 2005 967 974 (Pubitemid 43093963)
22. R. Folberg, M.J. Hendrix, and A.J. Maniotis Vasculogenic mimicry and tumor angiogenesis Am J Pathol 156 2000 361 381 (Pubitemid 30648785)
23. R. Folberg, and A.J. Maniotis Vasculogenic mimicry APMIS 112 2004 508 525 (Pubitemid 39626057)
24. R. Folberg, Z. Arbieva, J. Moses, A. Hayee, T. Sandal, and S. Kadkol Tumor cell plasticity in uveal melanoma: microenvironment directed dampening of the invasive and metastatic genotype and phenotype accompanies the generation of vasculogenic mimicry patterns Am J Pathol 169 2006 1376 1389 (Pubitemid 351194371)
25. J. Folkman Angiogenesis Annu RevMed 57 2006 1 18 (Pubitemid 43261975)
26. D. Hanahan, and J. Folkman Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis Cell 86 1996 353 364 (Pubitemid 26272076)
27. M.M. Handsley, and D.R. Edwards Metalloproteinases and their inhibitors in tumor angiogenesis Int J Cancer 115 2005 849 860 (Pubitemid 40791824)
28. T. Hato, M. Tabata, and Y. Oike The role of angiopoietin-like proteins in angiogenesis and metabolism Trends Cardiovasc Med 18 2008 6 14
29. O. Heby, and L. Persson Molecular genetics of polyamine synthesis in eukaryotic cells Trends Biochem Sci 15 1990 153 158 (Pubitemid 20186844)
30. F. Hillen, and A.W. Griffioen Tumour vascularization: sprouting angiogenesis and beyond Cancer Metastasis Rev 26 2007 489 502 (Pubitemid 350115123)
31. E. Holtta, A. Paasinen-Sohns, M. Povelainen, K. Jarvinen, K. Ravanko, and A. Kangas Cell transformation by ornithine decarboxylase is associated with phosphorylation of the transactivation domain of c-jun Biochem Soc Trans 26 1998 621 627 (Pubitemid 29008136)
32. J.O. Humtsoe, S. Feng, G.D. Thakker, J. Yang, J. Hong, and K.K. Wary Regulation of cell-cell interactions by phosphatidic acid phosphatase 2b/VCIP EMBO J 22 2003 1539 1554 (Pubitemid 36417403)
33. F.S. Jones, and P.L. Jones The tenascin family of ECM glycoproteins: structure, function, and regulation during embryonic development and tissue remodeling Dev Dyn 218 2000 235 259 (Pubitemid 30349638)
34. E. Kaariainen, P. Nummela, J. Soikkeli, M. Yin, M. Lukk, and T. Jahkola Switch to an invasive growth phase in melanoma is associated with tenascin-C, fibronectin, and procollagen-I forming specific channel structures for invasion J Pathol 210 2006 181 191 (Pubitemid 44463933)
35. S. Kazerounian, K.O. Yee, and J. Lawler Thrombospondins in cancer Cell Mol Life Sci 65 2008 700 712
36. M. Kielosto, P. Nummela, R. Katainen, V. Leaner, M.J. Birrer, and E. Holtta Reversible regulation of the transformed phenotype of ornithine decarboxylase- and ras-overexpressing cells by dominant-negative mutants of c-jun Cancer Res 64 2004 3772 3779 (Pubitemid 38697286)
37. M. Kielosto, P. Nummela, K. Jarvinen, M. Yin, and E. Holtta Identification of integrins alpha6 and beta7 as c-jun- and transformation- relevant genes in highly invasive fibrosarcoma cells Int J Cancer 125 2009 1065 1073
38. P. Kucharzewska, J.E. Welch, K.J. Svensson, and M. Belting Ornithine decarboxylase and extracellular polyamines regulate microvascular sprouting and actin cytoskeleton dynamics in endothelial cells Exp Cell Res 316 2010 2683 2691
39. L. Lan, C. Trempus, and S.K. Gilmour Inhibition of ornithine decarboxylase (ODC) decreases tumor vascularization and reverses spontaneous tumors in ODC/Ras transgenic mice Cancer Res 60 2000 5696 5703
40. J.R. MacFadyen, O. Haworth, D. Roberston, D. Hardie, M.T. Webster, and H.R. Morris Endosialin (TEM1, CD248) is a marker of stromal fibroblasts and is not selectively expressed on tumour endothelium FEBS Lett 579 2005 2569 2575 (Pubitemid 40615660)
41. M.A. Medina, R. Munoz-Chapuli, and A.R. Quesada Challenges of antiangiogenic cancer therapy: trials and errors, and renewed hope J Cell Mol Med 11 2007 374 382 (Pubitemid 47153451)
42. J.P. Morgenstern, and H. Land Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line Nucleic Acids Res 18 1990 3587 3596
43. A. Nanda, B. Karim, Z. Peng, G. Liu, W. Qiu, and C. Gan Tumor endothelial marker 1 (Tem1) functions in the growth and progression of abdominal tumors Proc Natl Acad Sci USA 103 2006 3351 3356 (Pubitemid 43346473)
44. H. Nozawa, C. Chiu, and D. Hanahan Infiltrating neutrophils mediate the initial angiogenic switch in a mouse model of multistage carcinogenesis Proc Natl Acad Sci USA 103 2006 12493 12498 (Pubitemid 44267286)
45. P. Nummela, M. Yin, M. Kielosto, V. Leaner, M.J. Birrer, and E. Holtta Thymosin beta4 is a determinant of the transformed phenotype and invasiveness of S-adenosylmethionine decarboxylase-transfected fibroblasts Cancer Res 66 2006 701 712 (Pubitemid 43165932)
46. P. Nyberg, L. Xie, and R. Kalluri Endogenous inhibitors of angiogenesis Cancer Res 65 2005 3967 3979 (Pubitemid 40775631)
47. G. Orend, and R. Chiquet-Ehrismann Tenascin-C induced signaling in cancer Cancer Lett 244 2006 143 163 (Pubitemid 44508708)
48. K.M. O'Rourke, C.D. Laherty, and V.M. Dixit Thrombospondin 1 and thrombospondin 2 are expressed as both homo- and heterotrimers J Biol Chem 267 1992 24921 24924
49. A. Paasinen-Sohns, and E. Holtta Cells transformed by ODC, c-HA-ras and v-src exhibit MAP kinase/Erk-independent constitutive phosphorylation of Sos, Raf and c-Jun activation domain, and reduced PDGF receptor expression Oncogene 15 1997 1953 1966 (Pubitemid 27480684)
50. A. Paasinen-Sohns, M. Kielosto, E. Kaariainen, T. Eloranta, A. Laine, and O.A. Janne c-Jun activation-dependent tumorigenic transformation induced paradoxically by overexpression or block of S-adenosylmethionine decarboxylase J Cell Biol 151 2000 801 810
51. M. Papetti, and I.M. Herman Mechanisms of normal and tumor-derived angiogenesis Am J Physiol Cell Physiol 282 2002 C947 C970
52. A.E. Pegg Polyamine metabolism and its importance in neoplastic growth and a target for chemotherapy Cancer Res 48 1988 759 774 (Pubitemid 18061860)
53. K. Ravanko, K. Jarvinen, A. Paasinen-Sohns, and E. Holtta Loss of p27Kip1 from cyclin E/cyclin-dependent kinase (CDK) 2 but not from cyclin D1/CDK4 complexes in cells transformed by polyamine biosynthetic enzymes Cancer Res 60 2000 5244 5253
54. K. Ravanko, K. Jarvinen, J. Helin, N. Kalkkinen, and E. Holtta Cysteine cathepsins are central contributors of invasion by cultured adenosylmethionine decarboxylase-transformed rodent fibroblasts Cancer Res 64 2004 8831 8838 (Pubitemid 39665486)
55. B. Ren, K.O. Yee, J. Lawler, and R. Khosravi-Far Regulation of tumor angiogenesis by thrombospondin-1 Biochim Biophys Acta 1765 2006 178 188
56. W.J. Rettig, P. Garin-Chesa, J.H. Healey, S.L. Su, E.A. Jaffe, and L.J. Old Identification of endosialin, a cell surface glycoprotein of vascular endothelial cells in human cancer Proc Natl Acad Sci USA 89 1992 10832 10836
57. D.D. Roberts Regulation of tumor growth and metastasis by thrombospondin-1 FASEB J 10 1996 1183 1191 (Pubitemid 26276960)
58. N. Sheibani, and W.A. Frazier Thrombospondin 1 expression in transformed endothelial cells restores a normal phenotype and suppresses their tumorigenesis Proc Natl Acad Sci USA 92 1995 6788 6792
59. L. Sistonen, E. Holtta, H. Lehvaslaiho, L. Lehtola, and K. Alitalo Activation of the neu tyrosine kinase induces the fos/jun transcription factor complex, the glucose transporter and ornithine decarboxylase J Cell Biol 109 1989 1911 1919 (Pubitemid 19282583)
60. J.L. Slack, and P. Bornstein Transformation by v-src causes transient induction followed by repression of mouse thrombospondin-1 Cell Growth Differ 5 1994 1373 1380 (Pubitemid 24381526)
61. J. Soikkeli, M. Lukk, P. Nummela, S. Virolainen, T. Jahkola, and R. Katainen Systematic search for the best gene expression markers for melanoma micrometastasis detection J Pathol 213 2007 180 189 (Pubitemid 47612240)
62. B. St Croix, C. Rago, V. Velculescu, G. Traverso, K.E. Romans, and E. Montgomery Genes expressed in human tumor endothelium Science 289 2000 1197 1202 (Pubitemid 30650733)
63. M. Streit, L. Riccardi, P. Velasco, L.F. Brown, T. Hawighorst, and P. Bornstein Thrombospondin-2: a potent endogenous inhibitor of tumor growth and angiogenesis Proc Natl Acad Sci USA 96 1999 14888 14893 (Pubitemid 30019735)
64. A.Y. Strongin Proteolytic and non-proteolytic roles of membrane type-1 matrix metalloproteinase in malignancy Biochim Biophys Acta 1803 2010 133 141
65. F. Svensson, H. Mett, and L. Persson CGP 48664, a potent and specific S-adenosylmethionine decarboxylase inhibitor: effects on regulation and stability of the enzyme Biochem J 322 Pt 1 1997 297 302 (Pubitemid 27095555)
66. K.J. Svensson, J.E. Welch, P. Kucharzewska, P. Bengtson, M. Bjurberg, and S. Pahlman Hypoxia-mediated induction of the polyamine system provides opportunities for tumor growth inhibition by combined targeting of vascular endothelial growth factor and ornithine decarboxylase Cancer Res 68 2008 9291 9301
67. M. Takigawa, M. Enomoto, Y. Nishida, H.O. Pan, A. Kinoshita, and F. Suzuki Tumor angiogenesis and polyamines: alpha-difluoromethylornithine, an irreversible inhibitor of ornithine decarboxylase, inhibits B16 melanoma-induced angiogenesis in ovo and the proliferation of vascular endothelial cells in vitro Cancer Res 50 1990 4131 4138 (Pubitemid 20225641)
68. M. Takigawa, Y. Nishida, F. Suzuki, J. Kishi, K. Yamashita, and T. Hayakawa Induction of angiogenesis in chick yolk-sac membrane by polyamines and its inhibition by tissue inhibitors of metalloproteinases (TIMP and TIMP-2) Biochem Biophys Res Commun 171 1990 1264 1271 (Pubitemid 20318088)
69. J.F. Talts, M. Falk, and M. Ekblom Expansion of the nonadherent myeloid cell population by monoclonal antibodies against tenascin-C in murine long-term bone marrow cultures Exp Hematol 26 1998 552 561 (Pubitemid 28307522)
70. A.T. Tikhonenko, D.J. Black, and M.L. Linial Viral myc oncoproteins in infected fibroblasts down-modulate thrombospondin-1, a possible tumor suppressor gene J Biol Chem 271 1996 30741 30747 (Pubitemid 26404093)
71. D.J. Toft, S.B. Rosenberg, G. Bergers, O. Volpert, and D.I. Linzer Reactivation of proliferin gene expression is associated with increased angiogenesis in a cell culture model of fibrosarcoma tumor progression Proc Natl Acad Sci USA 98 2001 13055 13059 (Pubitemid 33051316)
72. G. Vollmer Biologic and oncologic implications of tenascin-C/hexabrachion proteins Crit Rev Oncol Hematol 25 1997 187 210 (Pubitemid 27240181)
73. O.V. Volpert, J. Lawler, and N.P. Bouck A human fibrosarcoma inhibits systemic angiogenesis and the growth of experimental metastases via thrombospondin-1 Proc Natl Acad Sci USA 95 1998 6343 6348 (Pubitemid 28249014)
74. H.M. Wallace Targeting polyamine metabolism: a viable therapeutic/preventative solution for cancer? Expert Opin Pharmacother 8 2007 2109 2116 (Pubitemid 47505588)
75. R.S. Watnick, Y.N. Cheng, A. Rangarajan, T.A. Ince, and R.A. Weinberg Ras modulates myc activity to repress thrombospondin-1 expression and increase tumor angiogenesis Cancer Cell 3 2003 219 231 (Pubitemid 37443878)
76. D.L. Weinstat-Saslow, V.S. Zabrenetzky, K. VanHoutte, W.A. Frazier, D.D. Roberts, and P.S. Steeg Transfection of thrombospondin 1 complementary DNA into a human breast carcinoma cell line reduces primary tumor growth, metastatic potential, and angiogenesis Cancer Res 54 1994 6504 6511
77. Q. Yang, Y. Tian, S. Liu, R. Zeine, A. Chlenski, and H.R. Salwen Thrombospondin-1 peptide ABT-510 combined with valproic acid is an effective antiangiogenesis strategy in neuroblastoma Cancer Res 67 2007 1716 1724 (Pubitemid 46383398)
78. V. Zabrenetzky, C.C. Harris, P.S. Steeg, and D.D. Roberts Expression of the extracellular matrix molecule thrombospondin inversely correlates with malignant progression in melanoma, lung and breast carcinoma cell lines Int J Cancer 59 1994 191 195 (Pubitemid 24343361)
79. X. Zhang, and J. Lawler Thrombospondin-based antiangiogenic therapy Microvasc Res 74 2007 90 99 (Pubitemid 350064284)
80. Y.W. Zhang, Y. Su, O.V. Volpert, and G.F. Vande Woude Hepatocyte growth factor/scatter factor mediates angiogenesis through positive VEGF and negative thrombospondin 1 regulation Proc Natl Acad Sci USA 100 2003 12718 12723 (Pubitemid 37339965)